Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 1/2009

01-06-2009 | Original Paper

Antiretroviral Therapy is Associated with Increased Fertility Desire, but not Pregnancy or Live Birth, among HIV+ Women in an Early HIV Treatment Program in Rural Uganda

Authors: Marissa Maier, Irene Andia, Nneka Emenyonu, David Guzman, Angela Kaida, Larry Pepper, Robert Hogg, David R. Bangsberg

Published in: AIDS and Behavior | Special Issue 1/2009

Login to get access

Abstract

To assess the association between antiretroviral therapy (ART) and fertility history and desire among HIV-positive Ugandan women, we conducted a cross-sectional study among HIV-positive Ugandan women aged 18–50 years who attended an HIV clinic at Mbarara University in western Uganda between November 1, 2005 and June 6, 2006. Of 538 women approached, 501 were enrolled. ART use was associated with increased odds of fertility desire (AOR 2.99, 95% CI 1.38–6.28), and decreased odds of pregnancy (AOR 0.56, 95% CI 0.33–0.95) and live birth (AOR 0.30, 95% CI 0.13–0.66). ART was associated with an increase in fertility desire, but was not associated with an increase in fertility. Additional studies will be needed to determine if this greater fertility desire among ART-treated women leads to an increase in fertility as ART use expands.
Literature
Badri, M., Lawn, S. D., & Wood, R. (2006). Short-term risk of AIDS or death in people infected with HIV-1 before antiretroviral therapy in South Africa: A longitudinal study. The Lancet, 368(9543), 1254–1259.CrossRef
Badri, M., Wilson, D., & Wood, R. (2002). Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: A cohort study. The Lancet, 359(9323), 2059–2064.CrossRef
Bateganya, M., Colfax, G., Shafer, L. A., Kityo, C., Mugyenyi, P., Serwadda, D., Mayanja, H., & Bangsberg, D. (2005). Antiretroviral therapy and sexual behavior: A comparative study between antiretroviral- naive and -experienced patients at an urban HIV/AIDS care and research center in Kampala, Uganda. AIDS Patient Care and STDS, 19(11), 760–768.PubMedCrossRef
Blair, J. M., Hanson, D. L., Jones, J. L., & Dworkin, M. S. (2004). Trends in pregnancy rates among women with human immunodeficiency virus. Obstetrics and Gynecology, 103(4), 663–668.PubMed
Braitstein, P., Brinkhof, M. W., Dabis, F., Schechter, M., Boulle, A., Miotti, P., Wood, R., Laurent, C., Sprinz, E., Seyler, C., Bangsberg, D., Balestre, E., Sterne, J. A., May, M., & Egger, M. (2006). Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: Comparison between low-income and high-income countries. The Lancet, 367(9513), 817–824.CrossRef
Bunnell, R., Ekwaru, J. P., Solberg, P., Wamai, N., Bikaako-Kajura, W., Were, W., Coutinho, A., Liechty, C., Madraa, E., Rutherford, G., & Mermin, J. (2006). Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda. AIDS, 20(1), 85–92.PubMedCrossRef
Dukers, N. H., Goudsmit, J., de Wit, J. B., Prins, M., Weverling, G. J., & Coutinho, R. A. (2001). Sexual risk behaviour relates to the virological and immunological improvements during highly active antiretroviral therapy in HIV-1 infection. AIDS, 15(3), 369–378.PubMedCrossRef
Gray, R. H., Wawer, M. J., Serwadda, D., Sewankambo, N., Li, C., Wabwire-Mangen, F., Paxton, L., Kiwanuka, N., Kigozi, G., Konde-Lule, J., Quinn, T. C., Gaydos, C. A., & McNairn, D. (1998). Population-based study of fertility in women with HIV-1 infection in Uganda. The Lancet, 351(9096), 98–103.CrossRef
Homsy, J., Bennell, R., King, R., & Mermin, J. (2006). Determinants of Pregnancy Among Women Receiving HAART in Rural Uganda, Abstract 98. Paper presented at the PEPFAR Annual Meeting, 2006 HIV/AIDS Implementer’s Meeting. Durban, South Africa. June 12–15.
Kaida, A., Andia, I., Maier, M., Strathdee, S. A., Bangsberg, D. R., Spiegel, J., Bastos, F. I., Gray, G., & Hogg, R. (2006). The potential impact of antiretroviral therapy on fertility in sub-Saharan Africa. Current HIV/AIDS Reports, 3(4), 187–194.PubMedCrossRef
Katz, M. H., Schwarcz, S. K., Kellogg, T. A., Klausner, J. D., Dilley, J. W., Gibson, S., & McFarland, W. (2002). Impact of highly active antiretroviral treatment on HIV seroincidence among men who have sex with men: San Francisco. American Journal of Public Health, 92(3), 388–394.PubMedCrossRef
Kelly, J. A., Hoffman, R. G., Rompa, D., & Gray, M. (1998). Protease inhibitor combination therapies and perceptions of gay men regarding AIDS severity and the need to maintain safer sex. AIDS, 12(10), F91–F95.PubMedCrossRef
Lewis, J. J., Ronsmans, C., Ezeh, A., & Gregson, S. (2004). The population impact of HIV on fertility in sub-Saharan Africa. AIDS, 18(Suppl 2), S35–S43.PubMedCrossRef
Massad, L. S., Springer, G., Jacobson, L., Watts, H., Anastos, K., Korn, A., Cejtin, H., Stek, A., Young, M., Schmidt, J., & Minkoff, H. (2004). Pregnancy rates and predictors of conception, miscarriage and abortion in US women with HIV. AIDS, 18(2), 281–286.PubMedCrossRef
Mermin, J., Ekwaru, J. P., Liechty, C. A., Were, W., Downing, R., Ransom, R., Weidle, P., Lule, J., Coutinho, A., & Solberg, P. (2006). Effect of co-trimoxazole prophylaxis, antiretroviral therapy, and insecticide-treated bednets on the frequency of malaria in HIV-1–infected adults in Uganda: A prospective cohort study. The Lancet, 367(9518), 1256–1261.CrossRef
Miller, M., Meyer, L., Boufassa, F., Persoz, A., Sarr, A., Robain, M., & Spira, A. (2000). Sexual behavior changes and protease inhibitor therapy. SEROCO Study Group. AIDS, 14(4), F33–F39.PubMedCrossRef
Moatti, J. P., Prudhomme, J., Traore, D. C., Juillet-Amari, A., Akribi, H. A., & Msellati, P. (2003). Access to antiretroviral treatment and sexual behaviours of HIV-infected patients aware of their serostatus in Cote d’Ivoire. AIDS, 17(Suppl 3), S69–S77.PubMedCrossRef
Mohohlo, M., Khosa, T., Mohapi L, & Gray, G. (2006). Pregnancy-Related Events in an Antiretroviral Treatment Program, Abstract 113. Paper presented at the PEPFAR Annual Meeting, 2006 HIV/AIDS Implementer’s Meeting, Durban, South Africa. June 12–15.
Panozzo, L., Battegay, M., Friedl, A., & Vernazza, P. L. (2003). High risk behaviour and fertility desires among heterosexual HIV-positive patients with a serodiscordant partner-two challenging issues. Swiss Medical Weekly, 133(7–8), 124–127.PubMed
Ross, A., Van der Paal, L., Lubega, R., Mayanja, B. N., Shafer, L. A., & Whitworth, J. (2004). HIV-1 disease progression and fertility: The incidence of recognized pregnancy and pregnancy outcome in Uganda. AIDS, 18(5), 799–804.PubMedCrossRef
Scheer, S., Chu, P. L., Klausner, J. D., Katz, M. H., & Schwarcz, S. K. (2001). Effect of highly active antiretroviral therapy on diagnoses of sexually transmitted diseases in people with AIDS. The Lancet, 357(9254), 432–435.CrossRef
United Nations. (1997). World fertility patterns 1997 Africa. New York.
United Nations. (2005). Uganda Country Profile. New York.
UNAIDS. (2006). 2006 Report on the global AIDS epidemic. New York.
WHO. (2005). Core Health Indicators. Geneva.
WHO. (2006a). Core Health Indicators. Geneva.
WHO. (2006b). WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. Retrieved March 9, 2007, from WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. Geneva.
Wolf, K., Young, J., Rickenbach, M., Vernazza, P., Flepp, M., Furrer, H., Bernasconi, E., Hirschel, B., Telenti, A., Weber, R., & Bucher, H. C. (2003). Prevalence of unsafe sexual behavior among HIV-infected individuals: The Swiss HIV Cohort Study. Journal of Acquired Immune Deficiency Syndromes, 33(4), 494–499.PubMed
Zaba, B., & Gregson, S. (1998). Measuring the impact of HIV on fertility in Africa. AIDS, 12(Suppl 1), S41–S50.PubMed
Metadata
Title
Antiretroviral Therapy is Associated with Increased Fertility Desire, but not Pregnancy or Live Birth, among HIV+ Women in an Early HIV Treatment Program in Rural Uganda
Authors
Marissa Maier
Irene Andia
Nneka Emenyonu
David Guzman
Angela Kaida
Larry Pepper
Robert Hogg
David R. Bangsberg
Publication date
01-06-2009
Publisher
Springer US
Published in
AIDS and Behavior / Issue Special Issue 1/2009
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-008-9371-7

Other articles of this Special Issue 1/2009

AIDS and Behavior 1/2009 Go to the issue

Original Research

The Impact of HIV Status and Perceived Status on Fertility Desires in Rural Malawi

Original Paper

Longitudinal Antiretroviral Adherence in HIV+ Ugandan Parents and Their Children Initiating HAART in the MTCT-Plus Family Treatment Model: Role of Depression in Declining Adherence Over Time

Original Paper

PMTCT, HAART, and Childbearing in Mozambique: An Institutional Perspective

Original Paper

The WHOMEN’s Scale (Women’s HAART Optimism Monitoring and EvaluatioN Scale v.1) and the Association with Fertility Intentions and Sexual Behaviours Among HIV-Positive Women in Uganda

Original Paper

Perceptions of HIV and Fertility Among Adolescents in Soweto, South Africa: Stigma and Social Barriers Continue to Hinder Progress

Review paper

Strategies for Harm Reduction Among HIV-Affected Couples Who Want to Conceive
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits